Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 2

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 1
Chunk 2
---
 the esophagusLuden's Cough & Cold#3Cough Drops (Non-Medicated)Cough drop brand that is over 130 years old and includes a variety of flavorsMonistat Women's Health#1Vaginal Anti-FungalProvides fast relief for yeast infections and is available in several different dosesNix Dermatologicals#1Lice and Parasite TreatmentsEffective and safe lice and super lice treatmentsSummer's Eve Women's Health#1Feminine HygieneOffers a variety of feminine care products including washes, cloths and spraysTheraTearsEye & Ear Care#3Dry Eye ReliefDoctor created and recommended brand for dry eye reliefInternational OTC Healthcare: FessCough & Cold#1Nasal Saline Sprays and WashesHelps relieve nasal and sinus congestion due to allergy, hay fever, colds and fluHydralyteGastrointestinal#1Oral RehydrationRelieves symptoms of dehydration and helps replace water and electrolytes lost due to vomiting, diarrhea, heavy sweating, vigorous exercise and occasional hangovers 

(1)We have prepared the information included in this Annual Report on Form 10-K with regard to the market position for our brands based in part on data generated by Information Resources, Inc. (“IRI”), for the 52-week period ended March 23, 2025.  International information was derived from several sources.  Fess and Hydralyte data are for the Australian market. 

(2)“Market segment” is defined by us and is either a standard IRI category or a segment within a standard IRI category and is based on our product offerings and the categories in which we compete. 

(3)Some brands in the North American OTC Healthcare segment are also sold in the International OTC Healthcare segment.

Our products are sold through multiple channels, including mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores, which reduces our exposure to any single distribution channel.  

4

Market Position

During 2025, approximately 61.5% of our total revenues were from major brands with a number one market position, compared with approximately 58.6% and 58.1% of total revenues during 2024 and 2023, respectively.  In 2025, these brands included BC and Goody's, Chloraseptic, Compound W, Debrox, Dramamine, Fess, Fleet,